ALDOC and PGK1 coordinately induce glucose metabolism reprogramming and promote development of colorectal cancer
Abstract Colorectal cancer (CRC) remains a significant health challenge globally, demanding a comprehensive understanding of its molecular underpinnings for effective management. In this study, we investigated the role of Aldolase C (ALDOC), a glycolytic enzyme, in CRC pathogenesis. Transcriptomic a...
Saved in:
| Main Authors: | Liyong Huang, Yixin Tong, Xu Li, Wei Wang, Zhen Wang, Bingchen Chen, Jifu E., Ruzhen Zhou, Hantao Wang, Jinghu He |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s10020-025-01252-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ALDOC promotes neuroblastoma progression and modulates sensitivity to chemotherapy drugs by enhancing aerobic glycolysis
by: Yunpeng Chen, et al.
Published: (2025-04-01) -
Targeting PGK1: A New Frontier in Breast Cancer Therapy Under Hypoxic Conditions
by: Jiayong Cui, et al.
Published: (2024-10-01) -
Targeting PGK1 as a Novel strategy to regulate the sensitivity of HER2 positive gastric cancer to lapatinib
by: Xiaochen Ni, et al.
Published: (2025-07-01) -
Hsa_circ_0001756 drives gastric cancer glycolysis by increasing the expression and stability of PGK1 mRNA
by: Long Qian, et al.
Published: (2025-02-01) -
PGK1 can affect the prognosis and development of bladder cancer
by: Mingde Gao, et al.
Published: (2024-09-01)